1. Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy

   • Roisin M. Lonergan
   • Michael J. Carr
   • Niall J. Tubridy

   OriginalPaper Pages: 351 - 359

2. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy

   • I. Everall
   • F. Vaida
   • National NeuroAIDS Tissue Consortium (NNTC)

   OriginalPaper Pages: 360 - 370

3. Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat—modified lentiviral vectors

   • Kiyohiko Takayama
   • Takashi Torashima

   OriginalPaper Pages: 371 - 379

4. Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat

   • Harry L. June
   • Andrew Rong Song Tzeng Yang
   • Walter Royal

   OriginalPaper Pages: 380 - 389

5. Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array

   • Thorsten Nolting
   • Antje Lindecke
   • Competence Network HIV/AIDS

   OriginalPaper Pages: 390 - 400

6. Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage

   • Shuxian Hu
   • Wen S. Sheng
   • R. Bryan Rock

   OriginalPaper Pages: 401 - 410

7. A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system

   • Zane Zeier
   • J. Santiago Aguilar
   • David C. Bloom

   OriginalPaper Pages: 411 - 424

8. Chlamydia pneumoniae—specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms

   • Enrico Fainardi
   • Massimiliano Castellazzi
   • Carlo Contini

   OriginalPaper Pages: 425 - 433

9. Glycogen synthase kinase-3β (GSK-3β) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus—mediated neurotoxicity in primary human neurons

   • Timothy B. Nguyen
   • Ginger R. Lucero
   • HIV Neurobehavioral Research Group

   Short Communication Pages: 434 - 438

10. Identification of herpes simplex virus type 1 proteins encoded within the first 1.5 kb of the latency-associated transcript

    • Gail Henderson
    • Tareq Jaber
    • Clinton Jones

    Short Communication Pages: 439 - 448

11. GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity

    • Ajit G. Thomas
    • Amos Bodner
    • Barbara S. Slusher

    Short Communication Pages: 449 - 457

12. Advanced tracing tools: functional neuronal expression of virally encoded fluorescent calcium indicator proteins

    • Markus Rothermel
    • Daniela Brunert
    • Hanns Hatt

    Short Communication Pages: 458 - 464